Thomas Greuter Selected Research

Thomas Greuter Research Topics

Disease

14	Eosinophilic Esophagitis 03/2023 - 10/2017
11	Ulcerative Colitis 01/2022 - 11/2017
10	Crohn Disease (Crohn's Disease) 01/2022 - 01/2015
9	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 02/2016
4	Fibrosis (Cirrhosis) 01/2022 - 06/2016
4	Inflammation (Inflammations) 01/2022 - 06/2016
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 12/2017
3	Pathologic Constriction (Stenosis) 01/2022 - 01/2021
2	Liver Diseases (Liver Disease) 01/2022 - 01/2020
2	Portal Hypertension 01/2022 - 01/2020
2	Neoplasms (Cancer) 01/2020 - 01/2019
2	Osteoporosis 09/2019 - 06/2017
2	Pouchitis 11/2017 - 02/2016
1	Hepatitis D 02/2023
1	Esophageal Motility Disorders (Nutcracker Esophagus) 02/2023
1	Clinical Deterioration 01/2022
1	Fistula 01/2022
1	Meningitis 01/2022
1	Esophageal Achalasia (Megaesophagus) 09/2021
1	Gastroparesis 09/2021
1	Abdominal Pain (Pain, Abdominal) 02/2021
1	Arthritis (Polyarthritis) 01/2021
1	Infections 01/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Necrosis 01/2021
1	Hypersensitivity (Allergy) 12/2020
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 12/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Diarrhea 01/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Skin Neoplasms (Skin Cancer) 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Pain (Aches) 01/2019
1	Eosinophilia 03/2018
1	Pyoderma 02/2018
1	Erythema Nodosum 02/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2018
1	Proctitis 01/2018
1	Celiac Disease (Celiac Sprue) 03/2017

Drug/Important Bio-Agent (IBA)

8	SteroidsIBA 01/2022 - 10/2016
5	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 10/2017
3	AntibodiesIBA 02/2023 - 09/2019
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
3	Budesonide (Pulmicort)FDA LinkGeneric 12/2020 - 12/2018
3	Antisense OligonucleotidesIBA 01/2018 - 02/2016
3	alicaforsenIBA 01/2018 - 02/2016
2	tofacitinibIBA 01/2022 - 01/2021
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2020
2	TabletsIBA 12/2020 - 01/2020
2	Proton Pump InhibitorsIBA 01/2020 - 03/2018
2	Certolizumab Pegol FDA Link 01/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2020 - 12/2017
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2018 - 02/2016
1	dupilumabIBA 03/2023
1	upadacitinibIBA 02/2023
1	Antiviral Agents (Antivirals)IBA 02/2023
1	ozanimodIBA 02/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022
1	golimumab FDA Link 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Tumor Necrosis Factor InhibitorsIBA 01/2022
1	EnzymesIBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	AllergensIBA 01/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Infliximab (Remicade)FDA Link 01/2020
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Adalimumab (Humira)FDA Link 01/2020
1	Azathioprine (Imuran)FDA LinkGeneric 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2019
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2019
1	CollagenIBA 01/2019
1	Fluticasone (Cutivate)FDA LinkGeneric 12/2018
1	Caspase 3 (Caspase-3)IBA 02/2018
1	ZincIBA 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2017
1	Diphosphonates (Bisphosphonates)IBA 06/2017
1	Vitamin D FDA LinkGeneric 06/2017
1	CalciumIBA 06/2017
1	Glutens (Glutelin)IBA 03/2017
1	InflammasomesIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017

Therapy/Procedure

16	Therapeutics 02/2023 - 10/2015
2	Pyloromyotomy 02/2023 - 09/2021
2	Ligation 01/2022 - 01/2019
2	Colectomy 01/2021 - 06/2018
1	Gastrectomy 02/2023
1	Ostomy 01/2022
1	Myotomy 09/2021
1	Duration of Therapy 01/2021
1	Diet Therapy (Therapy, Diet) 01/2020
1	Gluten-Free Diet 01/2019
1	Aftercare (After-Treatment) 01/2018
1	Withholding Treatment 01/2018